Results 161 to 167 of about 902 (167)

Evogliptin: a new dipeptidyl peptidase inhibitor for the treatment of type 2 diabetes

Expert Opinion on Pharmacotherapy, 2016
exaly  

Dipeptidyl Peptidase‐4 Inhibitor Anagliptin Prevents Intracranial Aneurysm Growth by Suppressing Macrophage Infiltration and Activation

Journal of the American Heart Association, 2017
Sei Higuchi, Hiroharu Kataoka, Manabu Nagata   +2 more
exaly  

Ameliorating effect of the novel dipeptidyl peptidase‐4 inhibitor teneligliptin on psoriasis: A report of two cases

Journal of Dermatology, 2015
, Hiroshi Nagai, Chikako Nishigori
exaly  

Sitagliptin: A Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

Annals of Pharmacotherapy, 2006
exaly  

Genetically Targeted Dipeptidyl Peptidase-4 Inhibitor Use in a Patient with a Novel Mutation of MODY type 4

Clinical Medicine Insights: Endocrinology and Diabetes, 2015
Vijay Shivaswamy, Eric Rush
exaly  

Discovery of DA-1229: A potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes

Bioorganic and Medicinal Chemistry Letters, 2011
Chang Yell Shin
exaly  

Use of the dipeptidyl peptidase-4 inhibitor linagliptin in combination therapy for type 2 diabetes

Expert Opinion on Pharmacotherapy, 2012
exaly